Searched for
PHARMEASY IPO DATE
Think Investments infuses Rs 136 crore in PhysicsWallah ahead of IPOThink Investments has invested over Rs 136 crore in PhysicsWallah. This funding comes ahead of the edtech company's upcoming IPO next week....- ArisInfra Solutions sets price band for Rs 500 crore IPO, GMP signals 18% listing popArisInfra Solutions will launch its Rs 500 crore IPO from June 18–20, priced at Rs 210–222 per share. Backed by PharmEasy’s co-founder, the...
- Aris Infra files draft IPO papers, plans to raise Rs 600 croreMumbai-based Aris Infra intends to use the net proceeds from the IPO to repay and prepay outstanding borrowings, support its working capita...
- Unicommerce eSolutions IPO share allotment: Check status, GMP, listing date and other detailsUnicommerce eSolutions IPO share allotment was finalized, allocating shares based on a lottery system supervised by the registrar. Investor...
- PharmEasy fails to raise Rs 1,000 crore equity, breaches covenant on Goldman Sachs loanPharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...
- 2022 Year in Review | Is the startup IPO party over?The market for initial public offerings fell off a cliff in 2022 in India and around the world. In India, IPO activity saw a dramatic slowd...
- PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
- Institutional investors oppose Esops; PharmEasy drops IPO, targets Ebitda breakevenThe stock option plans of listed startups such as Zomato and Paytm are facing opposition from institutional investors for a variety of reas...
- PharmEasy delays IPO, targets Ebitda breakeven by next yearThe Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...
- BharatPe saga just won’t quit; PharmEasy may revise IPO valuationSeveral sources have told us that head of controls Madhuri Jain – who is also cofounder Ashneer Grover’s wife – wrote to the company board ...
- Oyo may reduce IPO size, valuation may be readjusted tooThe IPO issue size is expected to be much lower than $1 billion, these people said, while in its draft IPO papers with the markets regulato...
- Trifecta Capital raises Rs 1,500 crore towards final close of first equity fundThe late-stage equity fund will invest in leading startups that are likely to go in for a public listing in the next one to three years. Th...
- Fundraising will only get better in 2022, startup founders sayAlmost 92% of founders who attempted to raise capital in 2021 said they had a favourable experience and 75% of them expect the environment ...
- Demand soars for unlisted stocks of select IPO hopefulsIIFL Securities has sold over Rs 100 crore worth of PharmEasy stock to wealthy individuals at Rs 103 a share. Those shares traded at Rs 78 ...
- IPO pipeline expected to swell by over Rs 2 lakh crore in 2022: ReportThe year 2021 has seen the highest-ever IPO volumes in the country with the volumes surging to USD 15.3 billion, as against USD 4.2 billion...
- Sebi takes note of PE gains in startup IPOsThe Securities and Exchange Board of India (Sebi) has noted that these investors buy shares of startups at low prices and subsequently sell...
- The mother of all IPOsOn Nov. 8, 2016, Paytm splashed its ads on the front pages of India’s leading dailies, touting its e-wallet as the antidote to demonetisati...
- PharmEasy parent to file DRHP soon for Rs 6,000-7,000 crore IPOThe IPO of PharmEasy’s parent API Holdings is expected to be a fully primary share sale. The e-pharmacy — India’s largest — aims to list be...
- ETtech Deals Digest: PharmEasy, Cred raise funds this weekOnline pharmacy PharmEasy and credit card repayment platform Cred were among the startups that raised funds this week with a significant bu...
- Paytm courts Swiss RE, Info Edge cofounder on startup IPOsPaytm has been waiting for more than a year for regulators to approve its acquisition of general insurance firm Raheja QBE. Now, it is on t...
Load More
